CU6 clarity pharmaceuticals ltd

Umm ! I will await sufficient detail of the reason(s) why study...

  1. 726 Posts.
    lightbulb Created with Sketch. 202

    Umm ! I will await sufficient detail of the reason(s) why study results could not be provided by the deadline before drawing a final conclusion per The Good Cause Extension Request Process and Criteria guidelines attached below. For someone like myself though who is way outside their comfort zone on all things clinical trial and the reporting and registration process, the communication process in the first instance appears poor, so poor in fact, that I instinctively feel like I have missed a publication release of some type or other and or an intended or possible scenario still yet to be played.

    GCE_Criteria.pdf

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.51
Change
0.180(4.16%)
Mkt cap ! $1.458B
Open High Low Value Volume
$4.41 $4.57 $4.32 $8.931M 2.011M

Buyers (Bids)

No. Vol. Price($)
11 18969 $4.50
 

Sellers (Offers)

Price($) Vol. No.
$4.52 9799 13
View Market Depth
Last trade - 13.03pm 31/07/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.